Théa is an independent pharmaceutical company that specializes in the research, development and commercialization of eyecare products. Headquartered in France, the group has 35 subsidiaries across Europe, Russia, north and sub-Saharan Africa, and South America, and also works with distributors in other regions.
In 2021, Théa Group generated revenues of €683 million, of which one third was through its subsidiary in France.
Group treasurer Catherine Cledel manages a small treasury team with cash, treasury and risk-management responsibilities across the group’s global footprint.
Access intelligence that drives action
To unlock this research, enter your email to log in or enquire about access
